Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz


1. F8xny041cm
2. Unii-f8xny041cm
3. 2288850-57-5
4. Sovleplenib Acetate (usan)
5. Sovleplenib Acetate [usan]
6. (s)-7-(4-(1-(methylsulfonyl)piperidin-4-yl)phenyl)-n-(morpholin-2-ylmethyl)pyrido(4,3-b)pyrazin-5-amine Acetate
7. Pyrido(3,4-b)pyrazin-5-amine, 7-(4-(1-(methylsulfonyl)-4-piperidinyl)phenyl)-n-((2s)-2-morpholinylmethyl)-, Acetate (1:1)
8. Pyrido[3,4-b]pyrazin-5-amine, 7-[4-[1-(methylsulfonyl)-4-piperidinyl]phenyl]-n-[(2s)-2-morpholinylmethyl]-, Acetate (1:1)
9. Schembl22977619
10. Schembl29456586
11. D12954
12. 7-[4-[1-(methylsulfonyl)-4-piperidinyl]phenyl]-n-[(2s)-2-morpholinylmethyl]pyrido[3,4-b]pyrazin-5-amine Acetate
13. 7-{4-[1-(methanesulfonyl)piperidin-4-yl]phenyl}-n-{[(2s)-morpholin-2-yl]methyl}pyrido[3,4-b]pyrazin-5-amine Acetate
| Molecular Weight | 542.7 g/mol |
|---|---|
| Molecular Formula | C26H34N6O5S |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 11 |
| Rotatable Bond Count | 6 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 155 |
| Heavy Atom Count | 38 |
| Formal Charge | 0 |
| Complexity | 779 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
ABOUT THIS PAGE